User login
- /content/lenalidomide-rituximab-induces-high-cr-rate-untreated-follicular-lymphoma
- /hematologynews/article/140912/indolent-lymphoma/lenalidomide-rituximab-induces-high-cr-rate
- /oncologypractice/article/140912/indolent-lymphoma/lenalidomide-rituximab-induces-high-cr-rate
- /hematologynews/nhlhub/article/140912/indolent-lymphoma/lenalidomide-rituximab-induces-high-cr-rate
- /hematology-oncology/article/140912/indolent-lymphoma/lenalidomide-rituximab-induces-high-cr-rate
- /b-cell-lymphoma-icymi/article/140912/indolent-lymphoma/lenalidomide-rituximab-induces-high-cr-rate